High expression of Skp2 in tumors, accompanied by p27Kip1 downregulation, has been correlated with poor prognosis in cancer patients; Skp2 has also been implicated as a prognostic marker in many types of cancer, including prostate cancer17,18. The gene discussed is SKP2; the disease is cancer.